Clinical Trial Results

A Phase 1/1b Study of IAM1363 in HER2 Cancers

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve